Important Disclaimer: The peptides discussed in this article (BPC-157, TB-500, and others) are not FDA-approved for cosmetic or surgical recovery purposes
GLP-1 agonists may also have benefits for heart health, with research suggesting that they can reduce the risk of strokes, heart attacks, and death caused by cardiovascular disease by 20% compared to a placebo
Choosing between the two forms is easier with the right care team on your side
It might also be that females obtaining obesity treatments have a higher baseline migraine prevalence or higher triptan utilization, she said, making it easier to detect reductions in usage
Extended-release exenatide (Bydureon) uses a microsphere depot formulation that provides sustained release over time, allowing for weekly dosing despite different pharmacokinetics from other weekly agents
Diabetes medications and cancer risk associations: a systematic review and meta-analysis of evidence over the past 10 years